Explore more Norwegian companies →

COMPANY CARD COMPANY

DUSAVIK APOTEK AS

Business reg. no. 928 589 056ASSTAVANGERIndustry code 47.730

Retail sale of pharmaceutical products

Equity ratio: Weak · -1,6 % (2025)
Company financial statements in NOK · 2023: 11 222 482 NOK · 2024: 15 086 525 NOK · 2025: 16 718 458 NOK
2023–2025 · NOK
Operating revenue16,7 million NOK
2025 · company↑ 10,8 % from 2024
Company financial statements in NOK · 2023: -536 415 NOK · 2024: 369 957 NOK · 2025: -70 690 NOK
2023–2025 · NOK
Operating income · EBIT-70 690 NOK
2025 · company↓ 119,1 % from 2024

-0,4 % EBIT margin

Registered employees11 employees
RegisteredRegistry data 16.11.2026

FINANCIALS

Financial statements and key figures

Amount in whole currency units
Company financial statements

Amount in NOK

Company financial statements · amounts without rounding to thousands for display
Financial statement item202520242023
CurrencyNOKNOKNOK
Operating revenue16 718 45815 086 52511 222 482
Operating profit-70 690369 957-536 415
Net income-103 978272 148-646 500
Equity-61 84142 137-230 011
Total assets3 824 8333 921 7254 446 916
EBIT margin-0,4 %2,5 %-4,8 %

Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.

Show trend in NOK
Operating revenueNOK · 2023–202516,7 million NOK
↑ 10,8 % from 2024
Operating revenue202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Operating profitNOK · 2023–2025-70 690 NOK
↓ 119,1 % from 2024
Operating profit202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Sources and conversion basis

Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.

  • 2025 · NOK · original-NOK · source version 3440f8fcd9e0
  • 2024 · NOK · original-NOK · source version 972bb4cb2de3
  • 2023 · NOK · original-NOK · source version b925f9118295

Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.

Income statement12 entries with information
Company financial statements · Income statement · whole currency units
Financial statement item202520242023
Operating revenue
Total sales revenue16 718 45815 086 52511 215 275
Total operating revenue16 718 45815 086 52511 222 482
Operating expenses
Wage costs3 208 8482 385 3982 053 959
Total operating expenses16 789 14814 716 56711 758 896
Operating profit
Operating income (EBIT)-70 690369 957-536 415
Financial income
Total finance income382 499266
Financial expenses
Other interest expense33 326100 309—
Total finance costs33 326100 309110 351
Net finance result-33 288-97 810-110 085
Results and tax
Income before tax-103 978272 148-646 500
Tax expense on ordinary income000
Net income-103 978272 148-646 500
Balance sheet14 entries with information
Company financial statements · Balance sheet · whole currency units
Financial statement item202520242023
Financial fixed assets
Total non-current assets753 9991 064 5371 369 862
Current assets
Total inventory—1 371 9911 567 733
Total receivables769 095807 721412 465
Total investments00—
Total cash and cash equivalents614 923677 4761 096 856
Total current assets3 070 8342 857 1883 077 054
Total assets3 824 8333 921 7254 446 916
Equity
Total paid-in equity380 000380 000380 000
Total retained earnings-441 841-337 863-610 011
Total equity-61 84142 137-230 011
Provisions and long-term liabilities
Total long-term liabilities—782 0321 622 209
Current liabilities
Total current liabilities3 763 4703 097 5573 054 718
Total liabilities3 886 6743 879 5894 676 927
Total
Total equity and liabilities3 824 8333 921 7264 446 916
Executive salaryUnavailable

No information in the available financial statement data.

Reported annual amounts 2021–2022

Historical company accounts in NOK. The source identifies the year. A dash indicates an unavailable amount.

Financial statement item20212022
Operating revenue—6,452,000
Operating profit—111,000
Net income—41,000
Equity—416,000
Total assets—3,256,000
Total liabilities—2,839,000

REGISTRY INFORMATION

Company at a glance

Registered
Industry
47.730 · Retail sale of pharmaceutical products Industry classification: Statistics Norway · CC BY 4.0
Registered address
Dusavikveien 281A, 4029 STAVANGER
Founded
20.12.2021
Entity type
Main entity

ADDRESS AND PROPERTY

Property information

Open data

Dusavikveien 281A, 4029 STAVANGER

Loading property information …

© Kartverket · CC BY 4.0

Companies at the same address

Available company cards

    About the address match

    Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.

    REGISTERED ROLES

    The people and companies behind it.

    Search registered roles →Explore positions and documented connections.
    NameRoleSource date
    IREVISJON ASView role recordAuditor17.11.2026
    Hafiz Muhammad Nauman ShabbirBorn 1983General manager17.11.2026
    Hafiz Muhammad Nauman ShabbirBorn 1983Chair of the board17.11.2026
    ACCOUNTS ADVISER ASView role recordAccountant17.11.2026

    Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.

    YEAR-DATED OWNERSHIP

    Reported shareholders.

    Search shareholders →Find a shareholder and follow reported ownership entries.

    As of 31 December 2025 · 2 of 2 available ownership entries

    ShareholderShare / share classSource date
    FARMACARE HOLDING ASView ownership entryView share entries →65,00 % · Ordinary shares31.12.2025
    INOOR HOLDING ASView ownership entryView share entries →35,00 % · Ordinary shares31.12.2025
    Distribution of share count 31.12.2025
    100,0 %displayed share of shares
    • FARMACARE HOLDING ASOrdinary shares65,00 %
    • INOOR HOLDING ASOrdinary shares35,00 %

    Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.

    Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.

    Previously reported ownership entries (5)

    YEAR-DATED OWNERSHIP

    Company share entries

    The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.

    YEAR-DATED OWNERSHIP

    Indirect ownership

    Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.

    CONNECTIONS

    Explore the ownership structure.

    Directly reported ownership entries are shown first. Open the map to explore further.

    Direct ownership entries without an interactive map

    As of 31 December 2025 · 2 of 2 available ownership entries

    ShareholderShare / share classSource date
    FARMACARE HOLDING ASView ownership entryView share entries →65,00 % · Ordinary shares31.12.2025
    INOOR HOLDING ASView ownership entryView share entries →35,00 % · Ordinary shares31.12.2025

    Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.

    Open interactive map for direct ownership entries

    CONNECTIONS

    Explore the ownership structure.

    See owners and open further company levels, using the same year throughout the tree.

    Year-end ownership